FATTY LIVER DISEASE
Clinical trials for FATTY LIVER DISEASE explained in plain language.
Never miss a new study
Get alerted when new FATTY LIVER DISEASE trials appear
Sign up with your email to follow new studies for FATTY LIVER DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New fatty liver drug enters first human safety trial
Disease control Recruiting nowThis early-stage study tests whether a new medicine called NNC4005-0001 is safe and tolerable for adults with fatty liver disease and higher body weight. About 60 participants will receive either the drug or a placebo (inactive treatment) and be monitored for about 7-8 months. Th…
Matched conditions: FATTY LIVER DISEASE
Phase: PHASE1 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated May 26, 2026 10:35 UTC
-
Could a common heart drug be the key to reversing fatty liver disease?
Disease control Recruiting nowThis study tests if a low dose of digoxin, a drug currently used for heart conditions, can help people with NASH (a severe type of fatty liver disease). About 144 adults with NASH and liver scarring will take oral digoxin for a period. The goal is to see if the drug can reverse t…
Matched conditions: FATTY LIVER DISEASE
Phase: PHASE2 • Sponsor: Yale University • Aim: Disease control
Last updated May 19, 2026 12:00 UTC
-
Massive hospital record review seeks links between liver disease and other illnesses
Knowledge-focused Recruiting nowThis study looks at the medical records of 15,000 people to understand how chronic liver diseases (like hepatitis, fatty liver, and cirrhosis) are connected to other health problems. Researchers will track who develops liver cancer or serious liver complications over time. The go…
Matched conditions: FATTY LIVER DISEASE
Sponsor: Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation • Aim: Knowledge-focused
Last updated May 22, 2026 14:03 UTC